Although EpCAM expression is frequently lost during cancer progression in NSCLC, EpCAM expression in CTCs correlates with poorer outcome in previous studies8, while EpCAM negative CTCs failed to prove prognostic value in lung cancer10. The gene discussed is EPCAM; the disease is medical procedure.